Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Neurofibromatosis 1 × omipalisib × Other hematologic neoplasm × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1 CNS 1

Conditions

Neurofibromatosis 1 1 Leukemia, Myelomonocytic, Juvenile 1

Interventions

trametinib 2 fludarabine 2 thymoglobulin 1 omipalisib 1 fludarabine phosphate 1 Rituximab 1 Melphalan 1 Levetiracetam 1 Injections 1 Cytarabine 1 Cyclophosphamide 1 Busulfan 1 Biopsy 1 Azacitidine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03190915 2026-03-19

Trametinib in Treating Patients With Relapsed or Refractory Juvenile Myelomonocytic Leukemia

National Cancer Institute (NCI)

Phase 2 Active not recruiting

10 enrolled 11 charts

CNSOther hematologic neoplasm

Neurofibromatosis 1, Leukemia, Myelomonocytic, Juvenile

Data powered by HemOnc (CC BY 4.0) Colophon ⚡